US Patent 7625556 None
Patent 7625556 was granted and assigned to Intralytix on December, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Alexander Sulakvelidze0
Gary R. Pasternack0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+275 characters)
Article
Patent abstract
The present invention is directed to isolated bacteriophage having strong lytic activity against strains of E. coli, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of E. coli in various settings.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07625556 None US Patent 7625556 None
Infobox
Patent Number
076255560
Patent Number
76255560
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076255560
Date of Patent
December 1, 2009
0Patent Application Number
119551450
Date Filed
December 12, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07625556 None
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07625556
Date of patent
December 1, 2009
Patent application number
11955145
Date Filed
December 12, 2007
Patent primary examiner
Find more entities like US Patent 7625556 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.